The genetic ablation of Elp3 dramatically reduces breast cancer metastases in PyMT-induced breast cancer mouse models and affects cancer cell invasion in a mammary tumor ex vivo culture system [11]. The gene discussed is ELP3; the disease is breast carcinoma.